-
Product Insights
Prostaglandin F2 Alpha Receptor – Drugs In Development, 2023
Global Markets Direct’s Prostaglandin F2 Alpha Receptor provides in depth analysis on Prostaglandin F2 Alpha Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Prostaglandin F2 Alpha...
-
Product Insights
Fujairah F2 Power Plant Desalination
Fujairah F2 Power Plant Desalination is a thermal project located in Fujairah, United Arab Emirates. The project is owned by Abu Dhabi National Energy Co; Engie SA; Marubeni Corp and was developed by Fujairah Asia Power Company. The project came online in 2011. Empower your strategies with our Fujairah F2 Power Plant Desalination report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Bimatoprost Grenod in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bimatoprost Grenod in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bimatoprost Grenod in Open-Angle Glaucoma Drug Details: Bimatoprost grenod (NCX-470) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGN-193408 SR in Ocular Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGN-193408 SR in Ocular Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGN-193408 SR in Ocular Hypertension Drug Details: AGN-193408 SR is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGN-193408 SR in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGN-193408 SR in Open-Angle Glaucoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGN-193408 SR in Open-Angle Glaucoma Drug Details: AGN-193408 SR is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ILution Travoprost in Ocular Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ILution Travoprost in Ocular Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ILution Travoprost in Ocular Hypertension Drug Details: Travoprost is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ILution Travoprost in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ILution Travoprost in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ILution Travoprost in Open-Angle Glaucoma Drug Details: Travoprost is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GUR-701 in Androgenic Alopecia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GUR-701 in Androgenic Alopecia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GUR-701 in Androgenic Alopecia Drug Details: GUR-701 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PA-5108 in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PA-5108 in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PA-5108 in Open-Angle Glaucoma Drug Details: PA-5108 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Latanoprost in Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Latanoprost in Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Latanoprost in Glaucoma Drug Details:Latanoprost is under development for the treatment of glaucoma. It is...